Citations

Clear

6273 citation(s) found for "To, Andrew".

Effectiveness of Placebo Therapy for Maintaining Masking in a Clinical Trial of Vergence/Accommodative Therapy
Kulp, Marjean Taylor , Mitchell, G. Lynn , Borsting, Eric , Scheiman, Mitchell , Rouse, Michael , Tamkins, Susanna M. , Reuter, Kathleen, Cotter, Susan A. , Mohney, Brian G. , Toole, Andrew J.

Mayo Clinic

Investigative Opthalmology & Visual Science | May 26, 2009 | Volume: 50 | Issue: 6 | Pages: 2560

10.1167/iovs.08-2693 | PMID 19151384 Get It

Evidence-based medicine in obstetrics: can levels B and C recommendations be elevated to level A recommendations?
Group:, For the Evidenced-Based Medicine Obstetric, Chauhan, Suneet P. , Assel, Barbara G., Baxter, Jason K. , Grobman, Robert, Berghella, Vincenzo , Scardo, James A., Magann, Everett F. , Group:, For the Evidenced-Based Medicine Obstetric, Chang, Eugene , Brost, Brian , Smith, James Andrew Buchan , Morrison, John C.

Mayo Clinic

Obstetric Medicine | May 22, 2009 | Volume: 2 | Issue: 2 | Pages: 63-66

10.1258/om.2009.080031 | PMID 27582813 Get It

In this study, 65% (132/195) of level B/C obstetric recommendations are amenable to randomized clinical trials (RCTs) and seven were identified as most needed. The purpose of the survey was to evaluate levels B and C recommendations in obstetric practice bulletins (PBs) regarding the feasibility of performing RCT to elevate each subject to level A evidence. Eleven geographically dispersed physicians with experience in research reviewed levels B and C recommendations for the ethical and logistical feasibility of performing an RCT. In the 35 obstetric PBs, 195 level B/C recommendations were reviewed. The majority considered 47 (24%) topics unethical for an RCT and thought 16 (11%) did not need an RCT, thus leaving 132 (67%) levels B and C recommendations available for an RCT. Two-thirds of levels B and C recommendations in obstetric PB are amenable to RCTs and potentially becoming level A evidence.
Characterization of a Novel ADAM Protease Expressed byPneumocystis carinii
Kennedy, Cassie C. , Kottom, Theodore J. , Limper, Andrew H. , Kennedy, Cassie C

Mayo Clinic

Infection and Immunity | May 19, 2009 | Volume: 77 | Issue: 8 | Pages: 3328-3336

10.1128/iai.01383-08 | PMID 19451239 Get It

ABSTRACTPneumocystisspecies are opportunistic fungal pathogens that cause severe pneumonia in immunocompromised hosts. Recent evidence has suggested that unidentified proteases are involved inPneumocystislife cycle regulation. Proteolytically active ADAM (named for “a disintegrin and metalloprotease”) family molecules have been identified in some fungal organisms, such asAspergillus fumigatusandSchizosaccharomyces pombe, and some have been shown to participate in life cycle regulation. Accordingly, we sought to characterize ADAM-like molecules in the fungal opportunistic pathogen,Pneumocystis carinii(PcADAM). After an in silico search of theP. cariniigenomic sequencing project identified a 329-bp partial sequence with homology to known ADAM proteins, the full-length PcADAMsequence was obtained by PCR extension cloning, yielding a final coding sequence of 1,650 bp. Sequence analysis detected the presence of a typical ADAM catalytic active site (HEXXHXXGXXHD). Expression of PcADAMover thePneumocystislife cycle was analyzed by Northern blot. Southern and contour-clamped homogenous electronic field blot analysis demonstrated its presence in theP. cariniigenome. Expression of PcADAMwas observed to be increased inPneumocystiscysts compared to trophic forms. The full-length gene was subsequently cloned and heterologously expressed inSaccharomyces cerevisiae. Purified PcADAMp protein was proteolytically active in casein zymography, requiring divalent zinc. Furthermore, native PcADAMp extracted directly from freshly isolatedPneumocystisorganisms also exhibited protease activity. This is the first report of protease activity attributable to a specific, characterized protein in the clinically important opportunistic fungal pathogenPneumocystis.
Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral Clearance
Dickson, Rolland C. , Krishna, Mani , Lloyd, R, Aranda‐Michel, Jaime, Satyanarayana, Raj, Bonatti, Hugo , Ghabril, Marwan , Keaveny, Andrew P.

Mayo Clinic

Journal of Transplantation | May 5, 2009 | Volume: 2009 | Issue: No issue available | Pages: 1-6

10.1155/2009/297528 | PMID 20107579 Get It

Background. Hepatitis C virus (HCV) nondetectability in the liver may predict a sustained viral response (SVR) in patients with an end of treatment response. HCV RNA can be detected in liver tissue by in situ hybridization (ISH).Aim. To determine if HCV nondetectability in liver allografts by ISH can predict SVR in patients who cleared virus serologically on treatment.Methods. Twenty five patients with undetectable serum HCV on Interferon/Ribavirin therapy for HCV recurrence post liver transplant (LT) were studied. All had biopsies at 4 months post LT (baseline) and follow up with HCV ISH analysis performed.Results. 10 were ISH positive (group 1); 15 were ISH negative (group 2). Groups 1 and 2 had similar patient, donor, and viral characteristics at LT, as well as treatment duration at the time of the ISH assayed liver biopsy (13±16versus10±4monthsP= .24). However, group 1 had longer total treatment duration (24±10versus14±5months,P= .001). Eight (80%) group 1 and 9 (60%) group 2 patients achieved SVR. Mean grade and stage (modified Ishak score) were similar at 4 months, however, group 1 had higher grade (3±1.7versus1.6±1.3,P= .039) and stage (1.4±1.4versus0.5±0.6,P= .084) on the ISH assayed biopsy, after similar post LT intervals (23±10versus24±12months,P= .91).Conclusion. Allograft HCV ISH nondetectability does not predict SVR in treatment responsive HCV recurrence, but is associated with less severe histologic disease.
Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies
Lan, Qing , Morton, Lindsay M. , Hartge, Patricia, Menashe, Idan , Zheng, Tongzhang, Purdue, Mark P. , Cerhan, James R. , Grulich, Andrew E. , Holford, Theodore R. , Vajdic, Claire M. , Leaderer, Brian P., Kricker, Anne , Schenk, Maryjean, Zahm, Shelia Hoar , Chatterjee, Nilanjan , Rothman, Nathaniel , Wang, Sophia , Armstrong, Bruce K. , Zhang, Yawei , Cozen, Wendy , Yeager, Meredith , Davis, Scott , Chanock, Stephen Jacob , Cerhan, James R , Vajdic, Claire M , Morton, Lindsay M , Wang, Sophia S

Mayo Clinic

Blood | May 4, 2009 | Volume: 114 | Issue: 2 | Pages: 264-267

10.1182/blood-2009-01-198697 | PMID 19414860 Get It

Abstract Caspases play a critical role in regulation of apoptosis, cell differentiation, inflammation, and innate immunity, and several are mutated or have altered expression in non-Hodgkin lymphoma (NHL). To study the impact of genetic variation in caspases on NHL risk, we analyzed tag single nucleotide polymorphisms (SNPs) in 12 caspase and related genes in 3 population-based case-control studies (1946 cases and 1808 controls). Gene-based analysis, adjusting for the number of tagSNPs genotyped in each gene, showed significant associations for CASP8, CASP9, and CASP1. SNP-based analysis showed that CASP8 rs6736233 (odds ratio (OR) CG = 1.21; ORCC = 2.13; P trend = .011); CASP9 rs4661636 (ORCT = 0.89; ORTT = 0.77; P trend = .011); and CASP1 rs1785882 (ORAT = 1.12; ORAA = 1.30; P trend = .0054) were significantly associated with NHL risk and consistent across studies. It is noteworthy that genetic variants in CASP8 were associated with risk of all major NHL subtypes. Our findings suggest that genetic variation in caspases may play an important role in lymphomagenesis.
Melloni's Illustrated Review of Human Anatomy, 3rd ed.
Smith, Andrew R. M.

Mayo Clinic

American Journal of Roentgenology | April 21, 2009 | Volume: 192 | Issue: 5 | Pages: W270-W270

10.2214/ajr.08.2050 Get It

A Primer for Morpholino Use in Zebrafish
Bill, Brent , Petzold, Andrew M. , Clark, Karl J. , Schimmenti, Lisa A. , Ekker, Stephen C. , Ekker, Stephen C , Clark, Karl J , Schimmenti, Lisa A

Mayo Clinic

Zebrafish | April 17, 2009 | Volume: 6 | Issue: 1 | Pages: 69-77

10.1089/zeb.2008.0555 | PMID 19374550 Get It

Abstract Morpholino oligonucleotides are the most common anti-sense “knockdown” technique used in zebrafish ( Danio rerio ). This review discusses common practices for the design, preparation, and deployment of morpholinos in this vertebrate model system. Off-targeting effects of morpholinos are discussed as well as method to minimize this potentially confounding variable via co-injection of a tP53-targeting morpholino. Finally, new uses of morpholinos are summarized and contextualized with respect to the complementary, DNA-based knockout technologies recently developed for zebrafish.
Risk of Non–Hodgkin Lymphoma Associated with Germline Variation in Genes that Regulate the Cell Cycle, Apoptosis, and Lymphocyte Development
Morton, Lindsay M. , Purdue, Mark P. , Zheng, Tongzhang, Wang, Sophia , Menashe, Idan , Chatterjee, Nilanjan , Lan, Qing , Vajdic, Claire M. , Severson, Richard K., Holford, Theodore R. , Kricker, Anne , Cerhan, James R. , Leaderer, Brian P., Grulich, Andrew E. , Zahm, Shelia Hoar , Rothman, Nathaniel , Hartge, Patricia, Armstrong, Bruce K. , Zhang, Yawei , Davis, Scott , Yeager, Meredith , Cozen, Wendy , Chanock, Stephen Jacob , Cerhan, James R , Vajdic, Claire M , Morton, Lindsay M , Wang, Sophia S

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | April 8, 2009 | Volume: 18 | Issue: 4 | Pages: 1259-1270

10.1158/1055-9965.epi-08-1037 | PMID 19336552 Get It

AbstractChromosomal translocations are the hallmark genetic aberration in non–Hodgkin lymphoma (NHL), with specific translocations often selectively associated with specific NHL subtypes. Because many NHL-associated translocations involve cell cycle, apoptosis, and lymphocyte development regulatory genes, we evaluated NHL risk associated with common genetic variation in 20 candidate genes in these pathways. Genotyping of 203 tag single nucleotide polymorphisms (SNP) was conducted in 1,946 NHL cases and 1,808 controls pooled from 3 independent population-based case-control studies. We used logistic regression to compute odds ratios (OR) and 95% confidence intervals (CI) for NHL and four major NHL subtypes in relation to tag SNP genotypes and haplotypes. We observed the most striking associations for tag SNPs in the proapoptotic gene BCL2L11 (BIM) and BCL7A, which is involved in a rare NHL-associated translocation. Variants in BCL2L11 were strongly related to follicular lymphoma only, particularly rs3789068 (ORAG, 1.41; 95% CI, 1.10-1.81; ORGG, 1.65; 95% CI, 1.25-2.19; Ptrend = 0.0004). Variants in BCL7A were strongly related to diffuse large B-cell lymphoma only, particularly rs1880030 (ORAG, 1.34; 95% CI, 1.08-1.68; ORAA, 1.60; 95% CI, 1.22-2.08; Ptrend = 0.0004). The associations for both variants were similar in all three studies and supported by haplotype analyses. We also observed notable associations for variants in BCL6, CCND1, and MYC. Our results support the role of common genetic variation in cell cycle, apoptosis, and lymphocyte development regulatory genes in lymphomagenesis, and suggest that effects may vary by NHL subtype. Replication of our findings and further study to identify functional SNPs are warranted. (Cancer Epidemiol Biomarkers Prev 2009;18(4):1259–70)
Homophilic and heterophilic polycystin 1 interactions regulate E-cadherin recruitment and junction assembly in MDCK cells
Streets, Andrew J., Wagner, Bart , Harris, Peter C. , Ong, Albert , Ward, Christopher J. , Harris, Peter C , Ong, Albert C M

Mayo Clinic

Journal of Cell Science | April 8, 2009 | Volume: 122 | Issue: 9 | Pages: 1410-1417

10.1242/jcs.045021 | PMID 19351715 Get It

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited human renal disease and is caused by mutations in two genes, PKD1 (85%) and PKD2 (15%). Cyst epithelial cells are characterised by a complex cellular phenotype including changes in proliferation, apoptosis, basement membrane composition and apicobasal polarity. Since polycystin 1 (PC1), the PKD1 protein, has been located in the basolateral membrane of kidney epithelial cells, we hypothesised that it might have a key role in mediating or stabilising cell-cell interactions. In non-ciliated L929 cells, stable or transient surface expression of the PC1 extracellular domain was sufficient to confer an adhesive phenotype and stimulate junction formation. In MDCK cells, we found that PC1 was recruited to the lateral membranes coincident with E-cadherin within 30 minutes after a `calcium switch'. Recruitment of both proteins was significantly delayed when cells were treated with a PC1 blocking antibody raised to the PKD domains. Finally, PC1 and E-cadherin could be coimmunoprecipitated together from MDCK cells. We conclude that PC1 has a key role in initiating junction formation via initial homophilic interactions and facilitates junction assembly and the establishment of apicobasal polarity by E-cadherin recruitment.
Clinical and Histopathologic Features of Chordomas in Children and Young Adults
Ridenour, Robert V., Ahrens, William A., Folpe, Andrew L. , Miller, Dylan V. , Ahrens, William A.

Mayo Clinic

Pediatric and Developmental Pathology | April 6, 2009 | Volume: 13 | Issue: 1 | Pages: 9-17

10.2350/09-01-0584.1 | PMID 19348512 Get It

Chordoma is a tumor of the axial skeleton that is distinctly uncommon in children and adolescents. Previous observations have suggested that chordomas in pediatric patients differ from adult chordomas in presentation, morphology, and behavior. This study examines the clinical and histologic features of chordomas in young patients (≤25 years old). All cases from the Mayo Clinic files were graphed according to age and a bimodal distribution was observed. The 35 cases representing the youngest population were selected for review. Histopathology ranged from low cellularity tumors with lobulated architecture and abundant myxoid matrix (conventional chordoma), to those with varying amounts of chondroid matrix (chondroid chordoma), to more cellular tumors (atypical chordoma), and finally to neoplasms with high-grade spindle-cell differentiation (dedifferentiated chordoma). Over an average follow-up period of 129 months (range 1 to 501 months), there were 13 deaths (37%) and 3 patients with metastasis. This survival rate was slightly better than the reported mortality rate for adults with chordoma, but there was a subset of young patients (those with atypical chordoma) that had a significantly worse survival rate, suggesting that histologic subtyping may be predictive of prognosis.